
Diageo, Regencell Bioscience, and UP Fintech are the three Chinese stocks to watch today, according to MarketBeat’s stock screener tool. Chinese stocks are equity securities of companies that are incorporated in or derive most of their business from mainland China and are traded on exchanges such as Shanghai, Shenzhen, Hong Kong, or as ADRs/PNKs on foreign markets. For investors, the term covers different listing types (A?shares, H?shares, red chips, ADRs) and signals exposure to China?specific factors like local regulations, currency movements, economic growth, and corporate governance standards. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Read Our Latest Research Report on RGC
UP Fintech (TIGR)
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.
Read Our Latest Research Report on TIGR
See Also
- MarketBeat’s Top Five Stocks to Own in January 2026
- This ETF Is Proof That the Healthcare Rebound Is Real
- Why Smart Money Is Looking Overseas for Bank Stocks
- If Emerging Markets Outperform, This Stock Could Lead the Charge
- 3 Stocks Where Insiders Are Buying, Not Bailing
- These 3 Underrated ETFs Could Boom in 2026
